How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/high-grade-dysplasia-associated-with-barrett-s-esophagus.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

High Grade Dysplasia associated with Barrett's Esophagus — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

High Grade Dysplasia associated with Barrett's Esophagus (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating High Grade Dysplasia associated with Barrett's Esophagus, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	First approval
Photofrin	porfimer	Concordia Labs Inc	Photoactivated Radical Generator	1995-01-01
Photofrin	Photofrin	Samsung Medical Center
Photodyn	Hematoporphyrin	Hepatopancreatobiliary Surgery Institute of Gansu Province	hematoporphyrin

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Concordia Labs Inc · 1 drug in High Grade Dysplasia associated with Barrett's Esophagus
Hepatopancreatobiliary Surgery Institute of Gansu Province · 1 drug in High Grade Dysplasia associated with Barrett's Esophagus
Samsung Medical Center · 1 drug in High Grade Dysplasia associated with Barrett's Esophagus

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in High Grade Dysplasia associated with Barrett's Esophagus:

Cite this brief

Drug Landscape (2026). High Grade Dysplasia associated with Barrett's Esophagus — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/high-grade-dysplasia-associated-with-barrett-s-esophagus. Accessed 2026-06-10.

High Grade Dysplasia associated with Barrett's Esophagus full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing